Drug Sponsors

EnVivo Pharmaceuticals becomes FORUM Pharmaceuticals

Thursday, April 3, 2014 10:57 AM

EnVivo Pharmaceuticals has changed its name to FORUM Pharmaceuticals. The new name better reflects the company’s strong position as a late-stage, purpose-built organization that is focused on conquering brain diseases such as schizophrenia and Alzheimer’s disease. It is not associated with any changes in organizational structure or the company’s investor base.

More... »

WIRB Copernicus Group

GlaxoSmithKline invests in Africa

Wednesday, April 2, 2014 01:54 PM

GlaxoSmithKline has announced a series of new investments in sub-Saharan Africa designed to address pressing health needs and contribute to long-term business growth. GSK CEO Sir Andrew Wittyhasset out the company’s intent to partner with governments of African countries to help stimulate more research into chronic diseases, increase capacity by localizing medicines supply and strengthen healthcare infrastructure.

More... »


Perficient acquires BioPharm Systems

Wednesday, April 2, 2014 01:43 PM

Perficient, an information technology consulting firm serving Global 2000 and other large enterprise customers throughout North America, has acquired BioPharm Systems, a business and information technology consulting firm focused on the life sciences industry, for approximately $17.6 million, including about $11.4 million in cash and $6.2 million of Perficient common stock.

More... »

Annalisa Jenkins named IIR Partnerships’ Woman of the Year

Tuesday, April 1, 2014 01:43 PM

Annalisa Jenkins, former executive vice president, head of global R&D at Merck Serono, has been named IIR Partnerships’ Woman of the Year.

More... »

Baxter to split into two independent companies, separating biopharmaceutical development and medical products

Thursday, March 27, 2014 02:55 PM

Deerfield, Ill.-based Baxter International plans to create two separate, independent global healthcare companies—one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products.

More... »

Precision for Medicine acquires Hobart Group Holdings

Wednesday, March 26, 2014 11:43 AM

Precision for Medicine, formed in 2012 to support next-generation approaches to drug development and commercialization, has acquired Hobart Group Holdings, a market access firm.

More... »

AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K.

Wednesday, March 26, 2014 11:40 AM

AstraZeneca has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. The purchase was valued at approximately $102 million and gives AstraZeneca control of the entire shareholding of AstraZeneca K.K.

More... »

Report: Patients expect sponsors to help them manage their health

Friday, March 21, 2014 11:03 AM

Accenture, a global management consulting, technology services and outsourcing company, has released a survey of 2,000 patients in the U.S. taking long-term, short-term or lifestyle medications, which found that the vast majority (76%) believe pharmaceutical companies should provide services that complement the products they provide. 

More... »

NIH, three others earn AAHRPP accreditation

Thursday, March 20, 2014 02:46 PM

The nonprofit Association for the Accreditation of Human Research Protection Programs has accredited four more organizations: the U.S. National Institutes of Health; King Fahad Specialist Hospital-Dammam, Saudi Arabia; Taipei Medical University Hospital, Taiwan; and St. Jude Children’s Research Hospital, Memphis, Tenn.

More... »

StemTech to open Florida facility, hire 90

Wednesday, March 19, 2014 12:55 PM

Stemtech International, a stem cell technology company, will move its headquarters from San Clemente, Calif., to Pembroke Pines, Fla., creating 90 jobs.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs